#United States #Orlando #Coltrain Onsite #StaffDNA Cure Bowl #Orlando Sports Foundation

Coltrain Onsite Teams Up for the 2026 StaffDNA Cure Bowl

In a significant announcement for both the local and sports communities, Coltrain Onsite Fleet Care has been named an official sponsor of the upcoming 2026 StaffDNA Cure Bowl. This exciting collaboration brings together the family-owned mobile fleet maintenance company with the nonprofit Orlando Sports Foundation, further strengthening the fight against cancer through sports.

The Cure Bowl, now in its 12th year, is set to take place on December 22 at 5 p.m. ET, hosted live from the Acrisure Bounce House. The event will be broadcast on ESPN, showcasing not only an entertaining matchup but also the importance of raising awareness and funds for crucial cancer research. To date, the Cure Bowl has raised an impressive $6.83 million for cancer research initiatives, including over $3.68 million for the University of Central Florida (UCF) College of Medicine.

A Personal Commitment to the Cause

The Coltrain family’s involvement is deeply personal. Both Kyle and Kevin Coltrain, co-founders of Coltrain Onsite, have personal ties to the cause—having lost their grandmother to cancer. Coupled with their father's legacy as a football player at UCF and previous board president of the OSF, this sponsorship resonates not just as a corporate initiative but as a heartfelt commitment to combat a disease that has touched their lives.

The Heartbeat of American Commerce

Kyle Coltrain, now a board member of the OSF, emphasizes the critical role of logistics in supporting American commerce. He stated, "The road is the heartbeat of American commerce. Drivers, trucks, and trailers are its lifeblood. Our mobile technicians identify and resolve issues on our customers’ fleets early, ensuring safety and compliance on the road. This mirrors the mission of cancer researchers—defending health through early intervention." The slogan “Defend the Road. Defend the Cure” encapsulates the dual mission of Coltrain Onsite: to keep transport operations running smoothly while supporting efforts against cancer.

Uniting Teams for a Cure

According to Alan Gooch, the CEO of the Orlando Sports Foundation, the Cure Bowl is more than just a game; it symbolizes a unified battle against cancer. He praised Kyle Coltrain’s contributions, linking his past experiences as a team captain for UCF’s Knights to the meaningful efforts taking place off the field. "Every year, we face the matchup of Orlando vs. cancer, and today’s announcement of Coltrain Onsite joining our mission demonstrates the power of sports in uniting communities for a cause larger than themselves."

What’s Next?

Details regarding the matchup and ticket sales will be announced on December 6, culminating in a grand event that promises not only to entertain but to provide vital support for cancer research. Interested supporters can keep track of developments or donate directly through CureBowl.com.

About Coltrain Onsite Fleet Care

Based in Indianapolis, Coltrain Onsite Fleet Care specializes in mobile fleet maintenance, providing a spectrum of services, including preventive maintenance, inspections, and repairs across 15 states. The company’s commitment to quality and efficient service is evident in its operations, ensuring that Commerce stays on the road safely. Learn more at ColtrainOnsite.com.

About the Orlando Sports Foundation

The Orlando Sports Foundation is a recognized 501(c)(3) nonprofit focused on raising awareness and funding for cancer research initiatives in the community. Their collaboration with local and regional partners plays a crucial role in promoting health and well-being.

In conclusion, the sponsorship of the 2026 StaffDNA Cure Bowl by Coltrain Onsite Fleet Care is not just a business decision; it’s a commitment that reflects both personal loss and a strong desire to support cancer research initiatives. This partnership signifies how corporate entities can play an active role in community health and support, binding everyone together in the challenging fight against cancer.